June 24, 2026

Haisco and Nuvectis sign licensing deal for two drugs

​Haisco has signed an exclusive licensing agreement granting Nuvectis rights for two drug candidates in oncology and complement indications.The post...

June 24, 2026

Pfizer reports topline data from SigVie-002 study for NSCLC

​Pfizer has reported topline data from the Phase III SigVie-002 study investigating sigvotatug vedotin in adults with previously treated, locally...

June 24, 2026

CereVasc concludes patient enrolment in STRIDE trial of eShunt

​CereVasc has concluded patient enrolment in its STRIDE study, assessing the safety and effectiveness of the eShunt system for NPH.The...

June 23, 2026

Labcorp announces colorectal cancer test availability in US

​Labcorp has announced the US availability of ColoSense, its FDA-approved RNA-based at-home screening test for colorectal cancer.The post Labcorp announces...

June 23, 2026

Medidata establishes Academic Site Advisory Board for clinical trials

​Medidata has announced the formation of its Academic Site Advisory Board to advance collaboration to enhance the progress of clinical...

June 23, 2026

Lilly and BioArctic sign deal to develop neurodegenerative therapy

​Eli Lilly and Company has signed a research agreement with BioArctic to develop a potential treatment for neurodegenerative diseases.The post...

June 22, 2026

First participant receives Evategrel in CureGene’s trial

​CureGene Pharmaceutical has dosed the first participant in its pivotal clinical trial of Evategrel, a next-generation antiplatelet therapy, in the...

June 22, 2026

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

​Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE Trial, assessing the role of early mechanical thrombectomy...

June 22, 2026

Japan approves Sanofi’s Sarclisa combo for MM treatment

​Sanofi has received approval from Japan's Ministry of Health, Labour and Welfare for its SC formulation of Sarclisa in combination...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.